Nikoletta Papadopoulou

Summary

Publications

  1. ncbi request reprint Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria
    Nikoletta Papadopoulou
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    J Invest Dermatol 125:952-5. 2005
  2. ncbi request reprint Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor
    Jing Cao
    Department of Biochemistry, Tufts University School of Medicine, Boston, MA 02111, USA
    J Immunol 174:7665-75. 2005
  3. pmc Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells
    Duraisamy Kempuraj
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA 02111, USA
    Br J Pharmacol 145:934-44. 2005
  4. pmc Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process
    Jill Donelan
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Tufts New England Medical Center, 136 Harrison Avenue, Boston, MA 02111, USA
    Proc Natl Acad Sci U S A 103:7759-64. 2006
  5. ncbi request reprint Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin
    Duraisamy Kempuraj
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts New England Medical Center, Boston, MA 02111, USA
    Am J Reprod Immunol 52:267-75. 2004
  6. ncbi request reprint Mast cells as targets of corticotropin-releasing factor and related peptides
    Theoharis C Theoharides
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA
    Trends Pharmacol Sci 25:563-8. 2004
  7. pmc Mouse Eri1 interacts with the ribosome and catalyzes 5.8S rRNA processing
    K Mark Ansel
    Immune Disease Institute, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Struct Mol Biol 15:523-30. 2008
  8. ncbi request reprint Perifollicular and perivascular mouse skin mast cells express corticotropin-releasing hormone receptor
    Jill Donelan
    J Invest Dermatol 126:929-32. 2006

Collaborators

  • Koreaki Sugimoto
  • Grannum R Sant
  • Theoharis Theoharides
  • P Conti
  • Anjana Rao
  • Duraisamy Kempuraj
  • Jill Donelan
  • Jing Cao
  • K Mark Ansel
  • Dean Papaliodis
  • William Boucher
  • Curtis L Cetrulo
  • Bhuvaneshwari Madhappan
  • Spyridon Christodoulou
  • Yujiang Shi
  • Christine Wolf
  • Elke Glasmacher
  • Nicola Rath
  • Laura C Smith
  • Ariya D Lapan
  • Vigo Heissmeyer
  • Elisabeth Kremmer
  • Joachim W Ellwart
  • William A Pastor
  • Mamta Tahiliani
  • Edward D Lamperti
  • James E Marchand
  • Michael Lytinas
  • Paul Dobner
  • William S Boucher
  • Edward J Stanford
  • Kathleen Solage
  • Tayrickia Adams

Detail Information

Publications8

  1. ncbi request reprint Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria
    Nikoletta Papadopoulou
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    J Invest Dermatol 125:952-5. 2005
    ..The lichen simplex samples had high expression of CRH-R1, but low HDC. These results implicate CRH-R in chronic urticaria, which is often exacerbated by stress...
  2. ncbi request reprint Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor
    Jing Cao
    Department of Biochemistry, Tufts University School of Medicine, Boston, MA 02111, USA
    J Immunol 174:7665-75. 2005
    ..CRH-induced mast cell-derived VEGF could, therefore, be involved in chronic inflammatory conditions associated with increased VEGF, such as arthritis or psoriasis, both of which worsen by stress...
  3. pmc Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells
    Duraisamy Kempuraj
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA 02111, USA
    Br J Pharmacol 145:934-44. 2005
    ..Flavonols may therefore be suitable for the treatment of allergic and inflammatory diseases...
  4. pmc Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process
    Jill Donelan
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Tufts New England Medical Center, 136 Harrison Avenue, Boston, MA 02111, USA
    Proc Natl Acad Sci U S A 103:7759-64. 2006
    ..These findings suggest that CRH induces skin vascular permeability through NT acting on mast cells and that both peptides should be considered in the pathogenesis of skin disorders exacerbated by stress...
  5. ncbi request reprint Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin
    Duraisamy Kempuraj
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts New England Medical Center, Boston, MA 02111, USA
    Am J Reprod Immunol 52:267-75. 2004
    ..Mast cells had previously been reported to be increased at sites of endometriosis, and tryptase may contribute to the fibrosis and inflammation characterizing endometriosis...
  6. ncbi request reprint Mast cells as targets of corticotropin-releasing factor and related peptides
    Theoharis C Theoharides
    Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA
    Trends Pharmacol Sci 25:563-8. 2004
    ....
  7. pmc Mouse Eri1 interacts with the ribosome and catalyzes 5.8S rRNA processing
    K Mark Ansel
    Immune Disease Institute, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Struct Mol Biol 15:523-30. 2008
    ..8S rRNA 3' end processing. Taken together, our findings indicate that Eri1 catalyzes the final trimming step in 5.8S rRNA processing, functionally and spatially connecting this regulator of RNAi with the basal translation machinery...
  8. ncbi request reprint Perifollicular and perivascular mouse skin mast cells express corticotropin-releasing hormone receptor
    Jill Donelan
    J Invest Dermatol 126:929-32. 2006